New York, NY, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Pharmaceutical Dissolution Testing Services Market Share, Size, Trends, Industry ...

Key market opportunities in dissolution testing include optimizing drug bioavailability and enhancing quality control to meet regulatory demands. Understanding scientific principles and regulatory ...

Pharmaceutical Dissolution Market Pharmaceutical Dissolution Market Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The ...

The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of US$1.53 billion by 2033. This surge represents a substantial increase from the ...

The global Pharmaceutical Dissolution Testing Services Market is anticipated to reach US$ 693.12 Million in 2023 and US$ 1,538.48 Million by 2033, with a CAGR of 8.3% from 2023 to 2033. The expansion ...

The recall includes certain bottles of lisdexamfetamine dimesylate capsules, a generic version of the ADHD medication Vyvanse ...

Advances in dissolution testing equipment are helping to meet user demands to a certain degree; however, more innovation in the space may be necessary for novel therapies, such as biologics.

(NEXSTAR) – Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and ...

A widely prescribed ADHD medication is being recalled nationwide after tests found it failed to dissolve properly in lab ...

According to the FDA, 141,984 bottles of the 10mg medication were involved in the recall. The organization did not list ...